|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Rain Therapeutics (NASDAQ: RAIN) through any online brokerage.
The latest price target for Rain Therapeutics (NASDAQ: RAIN) was reported by Guggenheim on May 18, 2021. The analyst firm set a price target for 26.00 expecting RAIN to rise to within 12 months (a possible 48.91% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Rain Therapeutics (NASDAQ: RAIN) is $17.46 last updated Fri Jul 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Rain Therapeutics.
There is no upcoming split for Rain Therapeutics.
Rain Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.